Skip to main content
Caplight Logo









Sironax

Sironax

Private
BeijingHealthcare & Life Scienceshttps://www.sironax.com/

Last Round

Series B

Aug 2, 2022

Total Funding Raised

$300M

Company Overview

Sironax is a biotechnology company that develops innovative therapies for neurodegenerative, inflammatory, immunologic, and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologysmall-molecule therapeuticsdrug discoveryblood-brain barrierdrug delivery platformneurodegenerative diseasebrain delivery moduleBDMbiopharmaclinical-stage biotechSARM1 inhibitorRIPK1 inhibitorNAMPT activatordrug licensingCNS drug delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sironax Comparables

Compare Sironax with similar companies based on industry and business-model similarity.

Sironax comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tenvie Therapeutics
84%
Nura Bio
84%
Denali Therapeutics
81%

Sironax Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 2, 2022
Series AAug 1, 2019
Series AJul 1, 2019

Sironax Investors

Notable investors and investment history

Sironax investors
InvestorRounds
Longriver Investment PartnersSeries B
TemasekSeries A, Series B
MSA CapitalSeries B
ARCH Venture PartnersSeries A, Series B
F-Prime CapitalSeries A, Series B
Eight Roads VenturesSeries B, Series A
CBC GroupSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 2, 2022

    $200M round led by Yunfeng Capital and Gaorong Capital.

  • Aug 1, 2019

    $100M round with participation from Invus and Temasek.

Sironax Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sironax Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sironax's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range63
Year Founded2017
Last FundingAug 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?